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a  b  s  t  r  a  c  t
Caprine  arthritis–encephalitis  virus  (CAEV)  is  a lentivirus  that  causes  a chronic  and  degen-
erative arthritis  and  is  associated  with  important  economic  losses.  Adenosine  deaminase
(ADA)  levels  increase  in  some  human  infectious  diseases,  such  as  tuberculosis  and  acquired
immune  deﬁciency  syndrome.  Due  to the  similarity  between  CAEV  and  human  immunod-
eﬁciency  virus,  we  hypothesized  that  ADA  activity  in  goats  with  clinical  signs  of  CAEV
infection  is also  altered  and  could  serve  as  a  valuable  biochemical  marker.  Adenosine
deaminase  was  assayed  using  adenosine  (Ado)  or 2′-deoxyadenosine  (dAdo)  as  substrates,
and ADA  activity  was  calculated  using  the amount  of  ammonium  produced.  No  signif-
icant  difference  was  detected  in  the  activity  of the  serum  enzyme  when  assayed  with
Ado  (Km = 49.19  ±  5.28  mol/L)  or dAdo  (Km =  41.28  ±  4.58  mol/L).  Caprine  serum  ADA is a
thermo-stable  enzyme  and  can  be stored  at  cool  temperatures  for at least  30 days  with  no
loss  of  activity.  An  increase  in ADA  activity  (approximately  2.6-fold)  was  found  in  serum  and
synovial  ﬂuid  in  CAEV  infected  animals  with  clinical  signs  of  arthritis  compared  with  unin-
fected  animals.  In  serum,  the  ADA  cutoff  value  for CAEV  disease  using  Ado  was  >34.9  U/L.
Adenosine  deaminase  activity  may  be used  as  an  important  biochemical  marker  of the
inﬂammatory  response  induced  by  CAEV,  and  its determination  in serum  using  adenosine
as a simple  and  inexpensive  method  is sufﬁcient  to assess  the  pathological  condition  of  the
animal.
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Man  domesticated goats 10,000 years ago mainly
because they present great adaptability to several environ-
mental conditions and different nutritional regimens (Aziz,
2010). Especially in poor rural areas, goats are considered
an important source of milk, meat, and leather. Ofﬁcial data
estimate that Brazil has approximately 9 million goats, and
90% of the entire herd is located in the northeast region
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(IBGE, 2009). Despite ancestral domestication, the rear-
ing of goats also presents numerous problems, including
infectious diseases, that hinder the economic production of
these animals. Caprine arthritis–encephalitis virus (CAEV)
is a retrovirus that belongs to the lentivirus subfamily. It is a
common infection of goats causing arthritis and encephali-
tis (Narayan, 1990).
Originally, the caprine arthritis–encephalitis virus
(CAEV) was thought to only infect goats. However, recent
molecular epidemiological studies have shown that this
virus and visna/maedi virus represent a spectrum of vari-
ants that infect both sheep and goats in the ﬁeld and it
is now referred to as a small ruminant lentivirus (SRLV)
(Blacklaws, 2012).
The major CAEV tropism is for monocyte/macrophages
and dendritic cells. However, other cell types may  also be
infected and act as virus reservoirs. These additional targets
include epithelial cells in the mammary gland, which are
an important source of virus for transmission of the disease
from dams to their offspring (Blacklaws, 2012).
CAEV induced arthritis is characterized by a chronic
and degenerative process that mainly involves the tarsus
and metatarsus joints and progressive cachexia. Other clin-
ical signs of infection include encephalitis, mastitis and
pneumonitis. In the advanced phase of the arthritic form,
which is the most frequent manifestation of the disease, the
pelage becomes dry, and the animal loses weight with no
changes in appetite and walks on its knees (Cullen, 1992;
Frank, 1997; Perk, 1990).
A diagnosis of CAEV infection is often made by means
of the serologic detection of anti-viral antibodies. Other
tests for CAEV have been proposed using polymerase chain
reaction. However, these methods may  not be feasible or
ﬁnancially affordable for routine testing, especially in poor
areas or for large herds.
Adenosine is considered an important endogenous
inhibitor of the immune system for its potent suppres-
sor action in virtually all cells in the immune system
(Hasko and Cronstein, 2004). Its levels are modulated by
specialized enzymes. The enzyme adenosine deaminase
(ADA, E.C. 3.5.4.4) catalyzes the deamination of adenosine
(or 2′-deoxyadenosine [dAdo]) to produce inosine (or 2′-
deoxyinosine) and ammonium. Adenosine deaminase is
liberated from the monocytic-macrophage system during
the course of diseases caused by intracellular microor-
ganisms, and the monitoring of ADA activity is useful in
the diagnosis of human tuberculosis. However, ADA lev-
els can also increase in viral infections, such as acquired
immunodeﬁciency syndrome (AIDS) caused by human
immunodeﬁciency virus (HIV) (Gakis et al., 1989).
Because of the similarity between CAEV and HIV, we
hypothesized that ADA activity is altered in animals with
clinical signs of CAEV infection and could serve as a valuable
biochemical marker.
2. Materials and methods2.1. Chemicals
Adenosine (Ado) and dAdo were purchased from Sigma-Aldrich (USA).
Sodium nitroprusside was obtained from Merck (Germany). Disodium
monohydrogen phosphate (Na2HPO4) and sodium dihydrogen phosphatet Research 108 (2012) 120– 126 121
(NaH2PO4) were obtained from Labsynth (Brazil). Ammonium sulfate,
phenol, and sodium hydroxide were obtained from Reagen (Brazil).
Sodium hypochlorite was obtained from Vetec (Brazil).
2.2. Solutions
Adenosine and 2′-deoxyadenosine (22 mmol/L each) were dissolved
in  assay buffer that consisted of sodium phosphate buffer (50 mmol/L, pH
7.2). The phenol reagent consisted of phenol (106 mmol/L) and sodium
nitroprusside (0.17 mmol/L). Alkaline hypochlorite consisted of sodium
hypochlorite (11 mmol/L) in sodium hydroxide (125 mmol/L). The stan-
dard solution was ammonium sulfate (75 mol/L).
2.3. Experimental animals and sample collection
Crossbred goats of both sexes, aged 15–53 months with an average
weight of 50 kg, were obtained from farms near the city of Fortaleza,
State of Ceará, Brazil. The selection of the experimental animals was
based on the analysis of the clinical index for CAE (Monicat, 1987) and
ante-mortem inspection according to Brazilian law that prohibits the
trade of animals suspected of carrying zoonotic diseases such as CAEV,
babesiosis, brucellosis, anthrax, blackleg, foot and mouth disease, glan-
ders, paratuberculosis, rabies, tetanus, trypanosomiasis, tuberculosis, and
others diseases.
Clinical identiﬁcation of suspected cases of CAEV infection is based
on an interpretation of the “clinical index,” which is calculated as the
difference between the circumference of the carpus and metacarpus
(approximately 3 cm below the knee). The following parameters were
used as the “clinical index”: ≤5.5 (absent), 6.0–6.5 (suspected), ≥7.0 (pos-
itive). After animal selection, blood samples were collected for laboratory
conﬁrmation of disease by serological test (agar-gel immunodiffusion –
AGID).
Blood was collected from the jugular vein. The synovial ﬂuid was col-
lected only from animals slaughtered, immediately after the death of the
animal. The material for ADA activity determination was  transported to
the laboratory in an ice bath. For the evaluation of ADA levels in CAEV
induced arthritis, 64 animals were used for serum analysis, 48 with an
“absent” clinical index + negative antibody responses to CAEV (S−)  and 16
with a “positive” clinical index + positive antibody responses to CAEV (S+).
For the analysis of synovial ﬂuid, a total of 51 animals (38 S− and 13 S+)
were used.
After clot retraction, the material was centrifuged at 7840 × g at 4–6 ◦C
for  15 min. Joint ﬂuid was  treated similarly. The levels of ADA from the
supernatants were determined according to method described below.
The experimental protocols (protocol # 65/2011) were approved
by the Institutional Committee on the Care and Use of Animals for
Experimentation of Federal University of Ceará, in accordance with
the  guidelines of the Brazilian Committee of Animal Experimentation
(COBEA).
2.4. ADA assay
The ADA assay was performed according to the method described by
Giusti (1974),  with slight modiﬁcations. This assay is based on the quan-
tiﬁcation of ammonium ions produced by the deamination of Ado and
dAdo by ADA. Ado and dAdo (22 mmol/L – 200 L) in assay buffer were
incubated with 20 L of serum or synovial ﬂuid for 60 min  at 37 ◦C (ﬁrst
incubation period). Afterward, ammonia release was measured using the
Berthelot reaction (Berthelot, 1859; 600 L of phenol reagent plus 600 L
of  alkaline hypochlorite). The tubes were incubated again (second incuba-
tion period) at 37 ◦C for 30 min  and then read with a spectrophotometer
at 628 nm.
Control tubes that contained Ado or dAdo (200 L), standard tubes
that contained standard solution (200 L), and blank tubes that contained
only assay buffer (200 L) were also produced and subjected to the same
conditions as the experimental assays above, with the exception of the
absence of serum or synovial liquid during the ﬁrst incubation period.
Only after the addition of phenol reagent (600 L), the biological samples
(20 L) were added followed by alkaline hypochlorite (600 L).
Optimum conditions for the enzyme assay were then established.
Optimum pH, apparent Km , apparent Vmax, storage stability, thermal
effects, and thermal stability were determined using serum ADA.
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.5.  Optimum pH
Twenty microliters of sample (n = 8) were incubated with 200 L Ado
r  dAdo (22 mmol/L) in assay buffer with pH ranging from 6.0 to 8.0. The
ther procedures were the same as those described for the ADA assay.
.6. Kinetics parameters
Twenty microliters of sample (n = 9) were incubated with 200 L Ado
r  dAdo in assay buffer, with ﬁnal concentrations from 0 to 100 mol/L.
he other procedures were the same as those described for the ADA assay.
.7. Storage stability
Serum ADA activity was  evaluated from 1 to 30 days under different
torage conditions to establish how long it could be stored without loss.
he samples (n = 8) were stored at either 4 ◦C or −20 ◦C, frozen in liquid
itrogen and stored at −20 ◦C, or frozen and stored in liquid nitrogen at
176 ◦C. The analyses were performed 0, 1, 5, 15, and 30 days after col-
ection. On the speciﬁed days, the samples were analyzed for ADA activity
ccording to the procedures described for the ADA assay.
.8.  Thermal effect on serum ADA activity
The inﬂuence of incubation temperature (ﬁrst incubation period) on
he activity of ADA (n = 7) was evaluated by incubating the assay mix-
ure at temperatures that varied from 23 to 60 ◦C for 60 min. The others
rocedures were the same as those described for the ADA assay.
.9. Thermostability of serum ADA
Initially, serum samples alone (n = 6) were incubated in a water bath
t  53, 55, or 60 ◦C for 10, 20, 30, 40, 50, or 60 min. Afterward, the serum
amples were analyzed according to the procedures described for the ADA
ssay.
.10. Statistical analysis
The statistical analysis was  performed using GraphPad Prism 5.0 soft-
are. The experimental data are expressed as the mean ± standard error of
he mean (SEM) and were accepted as statistically signiﬁcant with P < 0.05
sing an unpaired t-test or the one way  analysis of variance (ANOVA)
ollowed by Tukey’s post hoc test (for multiple comparisons).
The ROC curve was  used to establish cutoff values (i.e., the cutoff
oint between normal and abnormal), sensitivity (i.e., the fraction of
ick animals correctly identiﬁed as positive), speciﬁcity (i.e., the fraction
f CAE-free animals correctly identiﬁed as negative), positive predictive
alue (PPV; i.e., the fraction of animals with positive tests that actually pre-
ented that condition), negative predictive value (NPV; i.e., the fraction of
nimals with negative tests that actually presented that condition), and
ositive likelihood ratio (LR; i.e., how many times more likely the animal
s to have the disease).
. Results
Caprine serum ADA presented maximum activity at
H 7.2 for both substrates (Ado and dAdo). The appar-
nt Km values for Ado and dAdo were 49.19 ± 5.28
nd 41.28 ± 4.58 mol/L, respectively (data not shown).
he Vmax values for Ado and dAdo were 0.815 ± 0.08
nd 0.775 ± 0.08 mol  NH3/h/ml, respectively (data not
hown).
A loss of enzymatic activity was not detected under the
stablished storage conditions (i.e., 4, −20, and −176 ◦C)
or up to 30 days. However, the samples that were stored
t 4 ◦C presented a high ammonia content after 15 days of
torage at the above temperatures in the blank and con-
rol assays, possibly attributable to protein degradation or
acteria growth.t Research 108 (2012) 120– 126
Adenosine deaminase activity presented increasing val-
ues when incubated for 60 min  (ﬁrst incubation period)
at temperatures from 23 ◦C to 55 ◦C. At 60 ◦C, a tendency
toward decreased activity was  observed. This effect was
observed for both substrates (Fig. 1a).
The preincubation of serum alone at 53 ◦C for 0–60 min
showed no loss of enzyme activity. Preincubation at 55 ◦C
showed a small loss of activity at 60 min. However, when
serum was preincubated at 60 ◦C, a decrease in activity
of approximately 32% was  observed beginning at 20 min,
reaching a decrease in activity of approximately 70% with
60 min  preincubation (Fig. 1b).
The use of Ado or dAdo did not signiﬁcantly change the
activity of the enzyme, either in serum or synovial ﬂuid. In
serum (Fig. 2a) and synovial ﬂuid (Fig. 2b), enzyme activ-
ity determined with both substrates increased signiﬁcantly
(about two-fold) in animals with CAEV induced arthritis
(S+) compared with uninfected animals (S−).
The cutoff values (Table 1) for ADA activity in clini-
cal CAEV disease calculated using ROC curves in serum
were 34.90 U/L (Ado) and 33.64 U/L (dAdo) and in syn-
ovial ﬂuid were 15.65 U/L (Ado) and 15.50 U/L (dAdo). The
areas under the ROC curves for serum ADA using Ado and
dAdo were 0.9896 (Fig. 3a; standard error [SE] = 0.00924;
95% conﬁdence interval [CI]: 0.9715–1.008) and 0.9870
(Fig. 3b; SE = 0.01039; 95% CI: 0.9666–1.007), respectively.
In synovial ﬂuid, the areas under the ROC curves using
Ado and dAdo were 0.9919 (Fig. 3c; SE = 0.009419; 95%
CI: 0.9734–1.010) and 1.000 (Fig. 3d; SE = 0.0; 95% CI:
1.000–1.000), respectively.
4. Discussion
The ﬁrst step of this study was  dedicated to investigat-
ing some of the characteristics of caprine ADA to establish
the best conditions for the determination of the enzyme,
especially storage conditions, thermostability, optimum
pH, and some kinetics parameters. This step was neces-
sary because of the absence of such data in the literature
(Harem et al., 2009).
The optimum pH and apparent Km for caprine serum
ADA suggest some similarities with the human ADA1 iso-
form. According to Gakis (1996),  human ADA1 presents
a Km of approximately 52 mol/L and an optimum pH of
7.0–7.5, whereas caprine ADA presented a Km of approxi-
mately 49 mol/L and an optimum pH of 7.2.
Although the samples could be stored for up to 30 days
with no loss of enzymatic activity, high ammonia content
can be detected after 15 days, at 4 ◦C, possibly due to protein
degradation or bacteria growth.
Serum ADA showed no loss of enzyme activity when
pre-incubated until 55 ◦C, but a signiﬁcant loss was found at
60 ◦C. Similar results were found for bovine ADA, which suf-
fers thermal unfolding at temperatures above 60 ◦C, while
the enzyme undergoes detectable conformational changes
during pre-unfolding heating (Tavirani et al., 2008).
The thermal stability of ADA facilitates collection, trans-
port, and laboratory analysis with no need for specialized
conditions for those procedures or storage.
ADA activity increases in clinical disease caused by
CAEV, at least in serum and in synovial ﬂuid. The increased
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Fig. 1. (a) Caprine serum ADA assayed with Ado or dAdo incubated at temperatures that ranged from 23 ◦C to 60 ◦C for 60 min. (b) Caprine serum ADA
ctivity iincubated with Ado after preincubation at 53, 55, or 60 ◦C for 0–60 min. A
t  = 0 min  (ANOVA followed by Tukey’s test).
levels of the enzyme in animals infected by CAEV and with
clinical disease suggest its involvement in the mechanisms
of the disease, possibly reﬂecting the activation of cell-
mediated immunity. Similarly high values for serum ADA
were found in bovine leukosis (Yasuda et al., 1996) and
HIV-positive patients (Gakis et al., 1989).
One of the ﬁrst clinical signs of CAEV infection fre-
quently observed in animals of at least 1 year of age is
arthritis characterized by the chronic degenerative inﬂam-
mation of carpometacarpal articulation, proliferation of
synovial membrane cells, deposits of ﬁbrinogen on synovial
surfaces, and sub-synovial inﬁltration of inﬂammatory
mononuclear cells (Crawford et al., 1980).
Table 1
Cutoff, sensitivity, speciﬁcity, PPV, NPV, and LR values for ADA activity in CAEV d
Fluid Substrate Cutoff (U/L) Sensitivity (%) (95% CI) 
Serum Ado 34.90 93.75 (69.77–99.84%) 
dAdo 33.64 93.75 (69.77–99.84%) 
Synovial Ado 15.65 92.31 (63.97–99.81%) 
dAdo  15.50 100.00 (75.29–100.0%) 
Ado, adenosine; dAdo, 2′-deoxyadenosine; PPV, positive predictive value; NPV, ns expressed as units per liter (U/L – mol  NH3/min/L) ± SEM. *P < 0.05 vs.
The natural immune response to CAEV is inadequate to
clear the virus, thus permitting the establishment of life-
long persistence in the infected host. However, the immune
response is sufﬁcient to keep virus replication at a low level,
slowing the progression of the disease (Fluri et al., 2006).
These characteristics suggest that increased ADA activ-
ity, both in serum and synovial ﬂuid in animals with
positive serology, should be a consequence of the involve-
ment of that system.
Little is known about human ADA2, but it does repre-
sent the main component of enzyme activity in human
serum when monocytes and macrophages are activated
(Shibagaki et al., 1996). Caprine tissues present at least
isease.
Speciﬁcity (%) (95% CI) PPV (%) NPV (%) LR
97.92 (88.93–99.95%) 93.75 97.92 45.00
95.83 (85.75–99.49%) 88.24 97.92 22.50
100.00 (90.75–100.0%) 100.00 97.44
100.00 (90.75–100.0%) 100.00 100.00
egative predictive value; LR, positive likelihood ratio.
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Fig. 2. ADA activity in animals with positive (S+) or negative (S−) antibody responses to CAEV. (a) Serum ADA activity. (b) Synovial ﬂuid ADA activity.
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hree ADA isoforms (Rodrigues et al., 2000), so investigat-
ng which isoform is responsible for increased ADA activity
n serum and synovial liquid after CAEV infection is impor-
ant. This information may  reveal the role of ADA in the
aprine immune system.
The study of the molecular weight and distribution of
DA isoforms in caprine tissue (Rodrigues et al., 2000)
howed similarities with other species (Lupidi et al., 1992),
ncluding humans (Gakis, 1996). However, serum caprine
soenzymes, in contrast to human ADA, did not exhibit sig-
iﬁcantly different afﬁnity for Ado and dAdo in the present
tudy.
Lymphocytes, macrophages, and other blood cells are
redominant in joint inﬁltration in CAEV induced arthritis
Norman and Smith, 1983). Increased ADA activity inunpaired t-test).
synovial ﬂuid may  result from the involvement of these
cells. Similar results were found in human patients with
rheumatoid arthritis, osteoarthritis, and reactive arthritis
(Yuksel and Akoglu, 1998).
The present study suggests the use of ADA activ-
ity as possible biochemical marker for the inﬂammatory
response induced by CAEV. However, it is important to
extend the study to infected animals with CAEV and with-
out clinical signs. Also, it should be interesting determining
which isoform is pivotal for increased ADA levels in the
disease.Our results demonstrated similarities in ADA kinetics
parameters and cutoff values for Ado and dAdo. Serum ADA
determination using only Ado (an inexpensive reagent)
may  be a useful diagnostic tool, making the collection
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Fig. 3. ROC curves plotted for ADA activity in clinical CAEV disease. (a) Serum incubated with Ado (area-under-the-curve [AUC]: 0.9896; SE = 0.00924; 95%
039; 95
Ado (ACI:  0.9715–1.008). (b) Serum incubated with dAdo (AUC: 0.9870; SE = 0.01
SE  = 0.009419; 95% CI: 0.9734–1.010). (d) Synovial ﬂuid incubated with d
the  line of no discrimination.
of synovial ﬂuid for diagnostic analysis unnecessary, thus
avoiding additional animal suffering.
5. Conclusion
Adenosine deaminase activity may  be used as an impor-
tant biochemical marker of the inﬂammatory response
induced by CAEV, and the determination of its activity in
serum using adenosine is a simple and inexpensive method
to assess the pathological condition of the animal.
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